FindTrial
Sign In

Efficacy of self-disclosure group intervention in patients with recurrence of systemic lupus erythematosus

Efficacy of self-disclosure group intervention in patients with recurrence of systemic lupus erythematosus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059893
Enrollment
Unknown
Registered
2022-05-13
Start date
2020-03-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus

Interventions

Group 1:Conventional treatment and nursing intervention
Group 2:Self-disclosure group intervention

Sponsors

Shanxi Bethune Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the SLE classification criteria proposed by the International Lupus Clinical Collaboration Group in 2019 and have been clinically confirmed as SLE; 2. Age >=18 years; 3. Correctly understand the content of the questionnaire; 4. Volunteer to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Accompanied by other critical diseases, including malignant tumor, heart failure, respiratory failure, severe trauma, etc.; 2. Participating in other researchers or refusing to participate in this study.

Design outcomes

Primary

MeasureTime frame
Alexithymia;—

Secondary

MeasureTime frame
Fear of disease progression;Quality of life;—

Countries

China

Contacts

Public ContactMiao Huali

Shanxi Bethune Hospital

574420441@qq.com+86 13935189252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026